Quarter
Charts

AMARIN CORP PLC\UK

AMRN

CIK 0000897448 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$45M
↑+7.4% +$3Mvs FY2025 (Q1)
Gross Profit
$18M
↓-29.3% -$7Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
58/100
  • Profitability
    0ROIC -8.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.34 (above 1.5 = solid)
  • Leverage
    96D/E 0.08 (under 0.5 = conservative)
  • Efficiency
    9Asset Turnover 0.32x (1.0+ = capital-efficient)
  • Growth
    41Revenue YoY +7.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -25.1% · trend +10.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project AMRN's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$0.28
Total enterprise IV
$116M
Diluted shares
0.41B
Terminal PV
$84M (72% of total)
Year-5 FCF
$10M
YearProjected FCFDiscounted PV
+1$7M$7M
+2$8M$6M
+3$8M$6M
+4$9M$6M
+5$10M$6M
Terminal$135M$84M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
—
investment in PP&E
Stock buybacks (TTM)
—
share count reduction
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$646M
everything owned
Total liabilities
$196M
everything owed
Stockholders' equity
$449M
shareholder claim
Net debt
$-122M
Net cash position ($122M)

Recent performance · 66 quarters

Revenue↑+7.4% +$3M
$45M
Net Income↑+33.0% +$5M
$-11M
Free Cash Flow↑+151.3% +$19M
$6M
Operating Margin↑+14.8pts
-25.1%

Drill down

AMRN Sankey

See AMARIN CORP PLC\UK's revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

AMRN Charts

66 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

AMRN Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics